TY  - JOUR
AU  - Cuneo, Antonio
AU  - Mato, Anthony R
AU  - Rigolin, Gian Matteo
AU  - Piciocchi, Alfonso
AU  - Gentile, Massimo
AU  - Laurenti, Luca
AU  - Allan, John N
AU  - Pagel, John M
AU  - Brander, Danielle M
AU  - Hill, Brian T
AU  - Winter, Allison
AU  - Lamanna, Nicole
AU  - Tam, Constantine S
AU  - Jacobs, Ryan
AU  - Lansigan, Frederick
AU  - Barr, Paul M
AU  - Shadman, Mazyar
AU  - Skarbnik, Alan P
AU  - Pu, Jeffrey J
AU  - Sehgal, Alison R
AU  - Schuster, Stephen J
AU  - Shah, Nirav N
AU  - Ujjani, Chaitra S
AU  - Roeker, Lindsey
AU  - Orlandi, Ester Maria
AU  - Billio, Atto
AU  - Trentin, Livio
AU  - Spacek, Martin
AU  - Marchetti, Monia
AU  - Tedeschi, Alessandra
AU  - Ilariucci, Fiorella
AU  - Gaidano, Gianluca
AU  - Doubek, Michael
AU  - Farina, Lucia
AU  - Molica, Stefano
AU  - Di Raimondo, Francesco
AU  - Coscia, Marta
AU  - Mauro, Francesca Romana
AU  - de la Serna, Javier
AU  - Medina Perez, Angeles
AU  - Ferrarini, Isacco
AU  - Cimino, Giuseppe
AU  - Cavallari, Maurizio
AU  - Cucci, Rosalba
AU  - Vignetti, Marco
AU  - Foà, Robin
AU  - Ghia, Paolo
AU  - GIMEMA, European Research Initiative (ERIC) on CLL, US study group
PY  - 2020
DO  - 10.1002/cam4.3470
UR  - https://hdl.handle.net/10668/26640
T2  - Cancer medicine
AB  - Limited information is available on the efficacy of front-line bendamustine and rituximab (BR) in chronic lymphocytic leukemia (CLL) with reduced renal function or coexisting conditions. We therefore analyzed a cohort of real-world patients and...
LA  - en
KW  - bendamustine
KW  - chronic lymphocytic leukemia
KW  - ibrutinib
KW  - real-world analysis
KW  - unfit patients
KW  - Adenine
KW  - Aged
KW  - Antineoplastic Agents, Alkylating
KW  - Antineoplastic Agents, Immunological
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bendamustine Hydrochloride
KW  - Disease Progression
KW  - Europe
KW  - Female
KW  - Humans
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - Male
KW  - Middle Aged
KW  - Piperidines
KW  - Progression-Free Survival
KW  - Protein Kinase Inhibitors
KW  - Retrospective Studies
KW  - Rituximab
KW  - Time Factors
KW  - United States
TI  - Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.
TY  - research article
VL  - 9
ER  -